ECTRIMS 2021

• What causes NMOSD? Clues from a Canadian Cohort

  Nov 08, 2021

• 

  ECTRIMS 2021: MRI & Clinical Features Discriminate Between MOGAD, AQP4-NMOSD & RR-MS

  Oct 25, 2021

• COVID-19 Vaccines Safe in Patients With NMOSD & MOGAD

  Oct 21, 2021

• Inebilizumab Sustains Efficacy & Safety During 5.5 Years

  Oct 21, 2021